Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers
Peter Bannas, Harald Kramer, Diego Hernando, Rashmi Agni, Ashley M. Cunningham, Rakesh Mandal, Utaroh Motosugi, Samir D. Sharma, Alejandro Munoz del Rio, Luis Fernandez, Scott B. Reeder – 29 July 2015 – Emerging magnetic resonance imaging (MRI) biomarkers of hepatic steatosis have demonstrated tremendous promise for accurate quantification of hepatic triglyceride concentration. These methods quantify the proton density fat‐fraction (PDFF), which reflects the concentration of triglycerides in tissue.